Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index ...

Dr. Reddy's Laboratories Ltd has generally positive cash flows and an excellent current ratio of 2.58. Additionally, the ...

Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along ...

With active COVID-19 cases crossing the 5,000 mark, the Indian Medical Association (IMA) has urged people to continue following preventive measures, including wearing masks and maintaining hygiene.

Dr. Reddy's Labs ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 16%.

Mayur Maheshwari, CEO of UPSIDA, said the Bulk Drug Pharma Park would be important in reducing India's dependence on China ...